Treatment and Outcome of Light Chain Deposition Disease in the Era of Novel Agents and Transplant
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Lorenz E, Gertz M, Fervenza F, Dispenzieri A, Lacy M, Hayman S
. Long-term outcome of autologous stem cell transplantation in light chain deposition disease. Nephrol Dial Transplant. 2008; 23(6):2052-7.
DOI: 10.1093/ndt/gfm918.
View
2.
Masood A, Ehsan H, Iqbal Q, Salman A, Hashmi H
. Treatment of Light Chain Deposition Disease: A Systematic Review. J Hematol. 2022; 11(4):123-130.
PMC: 9451548.
DOI: 10.14740/jh1038.
View
3.
Kastritis E, Migkou M, Gavriatopoulou M, Zirogiannis P, Hadjikonstantinou V, Dimopoulos M
. Treatment of light chain deposition disease with bortezomib and dexamethasone. Haematologica. 2008; 94(2):300-2.
PMC: 2635400.
DOI: 10.3324/haematol.13548.
View
4.
Matthai S, Jacob S, Devasia A, Bindra M, David V, Varughese S
. Unmasking and successful management of light chain deposition disease of kidney in pregnancy: a complex case, mirroring the complex needs of pregnancy with kidney disease in India. J Nephrol. 2018; 31(5):785-791.
DOI: 10.1007/s40620-018-0532-0.
View
5.
Nasr S, Valeri A, Cornell L, Fidler M, Sethi S, DAgati V
. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution. Clin J Am Soc Nephrol. 2011; 7(2):231-9.
DOI: 10.2215/CJN.08640811.
View